These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

692 related items for PubMed ID: 21173125

  • 1. FLT3 and NPM1 mutations in myelodysplastic syndromes: Frequency and potential value for predicting progression to acute myeloid leukemia.
    Bains A, Luthra R, Medeiros LJ, Zuo Z.
    Am J Clin Pathol; 2011 Jan; 135(1):62-9. PubMed ID: 21173125
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Investigation of FLT3-ITD and NPM1 mutations in patients with myelodysplastic syndrome and mixed myeloid diseases].
    Gritsaev SV, Martynkevich IS, Ivanova MP, Moskalenko MV, Aksenova VIu, Tiranova SA, Abdulkadyrov KM.
    Vopr Onkol; 2010 Jan; 56(6):671-6. PubMed ID: 21395122
    [Abstract] [Full Text] [Related]

  • 4. Amount of bone marrow blasts is strongly correlated to NPM1 and FLT3-ITD mutation rate in AML with normal karyotype.
    Haferlach T, Bacher U, Alpermann T, Haferlach C, Kern W, Schnittger S.
    Leuk Res; 2012 Jan; 36(1):51-8. PubMed ID: 21621842
    [Abstract] [Full Text] [Related]

  • 5. Clinical impact of nucleophosmin mutations and Flt3 internal tandem duplications in patients older than 60 yr with acute myeloid leukaemia.
    Scholl S, Theuer C, Scheble V, Kunert C, Heller A, Mügge LO, Fricke HJ, Höffken K, Wedding U.
    Eur J Haematol; 2008 Mar; 80(3):208-15. PubMed ID: 18081718
    [Abstract] [Full Text] [Related]

  • 6. Age-dependent frequencies of NPM1 mutations and FLT3-ITD in patients with normal karyotype AML (NK-AML).
    Schneider F, Hoster E, Schneider S, Dufour A, Benthaus T, Kakadia PM, Bohlander SK, Braess J, Heinecke A, Sauerland MC, Berdel WE, Buechner T, Woermann BJ, Feuring-Buske M, Buske C, Creutzig U, Thiede C, Zwaan MC, van den Heuvel-Eibrink MM, Reinhardt D, Hiddemann W, Spiekermann K.
    Ann Hematol; 2012 Jan; 91(1):9-18. PubMed ID: 21744003
    [Abstract] [Full Text] [Related]

  • 7. FLT3 and NPM1 mutations in a cohort of AML patients and detection of a novel mutation in tyrosine kinase domain of FLT3 gene from Western India.
    Ghosh K, Swaminathan S, Madkaikar M, Gupta M, Kerketta L, Vundinti B.
    Ann Hematol; 2012 Nov; 91(11):1703-12. PubMed ID: 22733614
    [Abstract] [Full Text] [Related]

  • 8. Association of cup-like nuclei in blasts with FLT3 and NPM1 mutations in acute myeloid leukemia.
    Park BG, Chi HS, Jang S, Park CJ, Kim DY, Lee JH, Lee JH, Lee KH.
    Ann Hematol; 2013 Apr; 92(4):451-7. PubMed ID: 23238897
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Influence of FLT3-internal tandem duplication allele burden and white blood cell count on the outcome in patients with intermediate-risk karyotype acute myeloid leukemia.
    How J, Sykes J, Gupta V, Yee KW, Schimmer AD, Schuh AC, Minden MD, Kamel-Reid S, Brandwein JM.
    Cancer; 2012 Dec 15; 118(24):6110-7. PubMed ID: 22736495
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Cytoplasmic expression of nucleophosmin accurately predicts mutation in the nucleophosmin gene in patients with acute myeloid leukemia and normal karyotype.
    Luo J, Qi C, Xu W, Kamel-Reid S, Brandwein J, Chang H.
    Am J Clin Pathol; 2010 Jan 15; 133(1):34-40. PubMed ID: 20023256
    [Abstract] [Full Text] [Related]

  • 13. Mutations and treatment outcome in cytogenetically normal acute myeloid leukemia.
    Schlenk RF, Döhner K, Krauter J, Fröhling S, Corbacioglu A, Bullinger L, Habdank M, Späth D, Morgan M, Benner A, Schlegelberger B, Heil G, Ganser A, Döhner H, German-Austrian Acute Myeloid Leukemia Study Group.
    N Engl J Med; 2008 May 01; 358(18):1909-18. PubMed ID: 18450602
    [Abstract] [Full Text] [Related]

  • 14. Serial determination of FLT3 mutations in myelodysplastic syndrome patients at diagnosis, follow up or acute myeloid leukaemia transformation: incidence and their prognostic significance.
    Georgiou G, Karali V, Zouvelou C, Kyriakou E, Dimou M, Chrisochoou S, Greka P, Dufexis D, Vervesou E, Dimitriadou E, Efthymiou A, Petrikkos L, Dima K, Lilakos K, Panayiotidis P.
    Br J Haematol; 2006 Aug 01; 134(3):302-6. PubMed ID: 16787503
    [Abstract] [Full Text] [Related]

  • 15. Clinical implications of non-A-type NPM1 and FLT3 mutations in patients with normal karyotype acute myeloid leukemia.
    Park BG, Chi HS, Park SJ, Min SK, Jang S, Park CJ, Kim DY, Lee JH, Lee JH, Lee KH.
    Acta Haematol; 2012 Aug 01; 127(2):63-71. PubMed ID: 22104247
    [Abstract] [Full Text] [Related]

  • 16. Prognostic factors in normal karyotype acute myeloid leukemia in the absence of the FLT3-ITD mutation.
    Jiang A, Jiang H, Brandwein J, Kamel-Reid S, Chang H.
    Leuk Res; 2011 Apr 01; 35(4):492-8. PubMed ID: 20684989
    [Abstract] [Full Text] [Related]

  • 17. C/EBPA gene mutation and C/EBPA promoter hypermethylation in acute myeloid leukemia with normal cytogenetics.
    Lu Y, Chen W, Chen W, Stein A, Weiss LM, Huang Q.
    Am J Hematol; 2010 Jun 01; 85(6):426-30. PubMed ID: 20513120
    [Abstract] [Full Text] [Related]

  • 18. Favorable outcome in patients with acute myelogenous leukemia with the nucleophosmin gene mutation autografted after conditioning with high-dose continuous infusion of idarubicin and busulfan.
    Ferrara F, Izzo T, Criscuolo C, Riccardi C, Muccioli G, Viola A, Pane F, Palmieri S.
    Biol Blood Marrow Transplant; 2010 Jul 01; 16(7):1018-24. PubMed ID: 20172040
    [Abstract] [Full Text] [Related]

  • 19. Importance of early detection and follow-up of FLT3 mutations in patients with acute myeloid leukemia.
    Colovic N, Tosic N, Aveic S, Djuric M, Milic N, Bumbasirevic V, Colovic M, Pavlovic S.
    Ann Hematol; 2007 Oct 01; 86(10):741-7. PubMed ID: 17579862
    [Abstract] [Full Text] [Related]

  • 20. FLT3 internal tandem duplication during myelodysplastic syndrome follow-up: a marker of transformation to acute myeloid leukemia.
    Pinheiro RF, de Sá Moreira E, Silva MR, Alberto FL, Chauffaille Mde L.
    Cancer Genet Cytogenet; 2008 Jun 01; 183(2):89-93. PubMed ID: 18503825
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.